Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
Background: Intravenous aminoglycoside antibiotics are widely used to treat pulmonary infection with Pseudomonas aeruginosa in individuals with cystic fibrosis (CF). Over the last decade evidence has accumulated showing that the choice of aminoglycoside and the dosing regimen may help reduce adverse...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
Elsevier
2014
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/31672/ |
| _version_ | 1848794249460449280 |
|---|---|
| author | Smyth, Alan R. Campbell, Emma L. |
| author_facet | Smyth, Alan R. Campbell, Emma L. |
| author_sort | Smyth, Alan R. |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | Background: Intravenous aminoglycoside antibiotics are widely used to treat pulmonary infection with Pseudomonas aeruginosa in individuals with cystic fibrosis (CF). Over the last decade evidence has accumulated showing that the choice of aminoglycoside and the dosing regimen may help reduce adverse effects such as nephrotoxicity.
Methods: We undertook an online survey to determine current practice in UK CF Centres.
Results: We received a response from 35/48 (73%) centres. A once daily regimen was used in 30/35 (86%) centres. Around one third had stopped using gentamicin in the last 10 years. In most cases respondents reported changing practice in response to new evidence or evidence based guidelines. Obstacles to introducing evidence based practice were identified both at the level of the CF Centre and the hospital trust.
Conclusions: A once daily aminoglycoside regimen is now used in the majority of UK CF Centres. Tobramycin is first line and many centres have stopped using gentamicin. Obstacles to evidence based practice remain in a minority of centres. |
| first_indexed | 2025-11-14T19:13:11Z |
| format | Article |
| id | nottingham-31672 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| last_indexed | 2025-11-14T19:13:11Z |
| publishDate | 2014 |
| publisher | Elsevier |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-316722020-05-04T20:14:13Z https://eprints.nottingham.ac.uk/31672/ Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey Smyth, Alan R. Campbell, Emma L. Background: Intravenous aminoglycoside antibiotics are widely used to treat pulmonary infection with Pseudomonas aeruginosa in individuals with cystic fibrosis (CF). Over the last decade evidence has accumulated showing that the choice of aminoglycoside and the dosing regimen may help reduce adverse effects such as nephrotoxicity. Methods: We undertook an online survey to determine current practice in UK CF Centres. Results: We received a response from 35/48 (73%) centres. A once daily regimen was used in 30/35 (86%) centres. Around one third had stopped using gentamicin in the last 10 years. In most cases respondents reported changing practice in response to new evidence or evidence based guidelines. Obstacles to introducing evidence based practice were identified both at the level of the CF Centre and the hospital trust. Conclusions: A once daily aminoglycoside regimen is now used in the majority of UK CF Centres. Tobramycin is first line and many centres have stopped using gentamicin. Obstacles to evidence based practice remain in a minority of centres. Elsevier 2014-07 Article PeerReviewed Smyth, Alan R. and Campbell, Emma L. (2014) Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey. Journal of Cystic Fibrosis, 13 (4). pp. 424-427. ISSN 1873-5010 Cystic fibrosis; aminoglycosides; nephrotoxicity; once daily dosing; obstacles to evidence based practice http://www.sciencedirect.com/science/article/pii/S1569199313001975 doi:10.1016/j.jcf.2013.11.007 doi:10.1016/j.jcf.2013.11.007 |
| spellingShingle | Cystic fibrosis; aminoglycosides; nephrotoxicity; once daily dosing; obstacles to evidence based practice Smyth, Alan R. Campbell, Emma L. Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey |
| title | Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey |
| title_full | Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey |
| title_fullStr | Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey |
| title_full_unstemmed | Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey |
| title_short | Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey |
| title_sort | prescribing practices for intravenous aminoglycosides in uk cystic fibrosis clinics: a questionnaire survey |
| topic | Cystic fibrosis; aminoglycosides; nephrotoxicity; once daily dosing; obstacles to evidence based practice |
| url | https://eprints.nottingham.ac.uk/31672/ https://eprints.nottingham.ac.uk/31672/ https://eprints.nottingham.ac.uk/31672/ |